Investing.com - GW Pharma (NASDAQ:GWPH) ADR reported on Monday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
GW Pharma ADR announced earnings per share of $-0.05 on revenue of $152.5M. Analysts polled by Investing.com anticipated EPS of $-0.0219 on revenue of $158.24M.
GW Pharma ADR shares are up 89.77% from the beginning of the year, still down 0.25% from its 52 week high of $219.57 set on May 3. They are outperforming the EUR/USD which is down 0% from the start of the year.
GW Pharma ADR follows other major Healthcare sector earnings this month
GW Pharma ADR's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Pfizer had beat expectations on Tuesday with first quarter EPS of $0.93 on revenue of $14.58B, compared to forecast for EPS of $0.7773 on revenue of $13.67B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar